They found that tumor-derived IgG, which was purified from ovarian cancer tissue, could suppress the proliferation of CD4+ or CD8+ T cells derived from cord blood monocyte cells and cord blood lymphocyte (CBL). This evidence concerns the gene CD8A and neoplasm.